Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3ugc | 046 | Tyrosine-protein kinase JAK2 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3ugc | 046 | Tyrosine-protein kinase JAK2 | / | 1.000 | |
| 3nnu | EDB | Mitogen-activated protein kinase 14 | / | 0.544 | |
| 3wze | BAX | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.544 | |
| 3p5k | P5K | Mitogen-activated protein kinase 14 | / | 0.539 | |
| 3p7b | P7B | Mitogen-activated protein kinase 14 | / | 0.523 | |
| 3hv6 | R39 | Mitogen-activated protein kinase 14 | / | 0.522 | |
| 1wbt | WBT | Mitogen-activated protein kinase 14 | / | 0.520 | |
| 3gi3 | B10 | Mitogen-activated protein kinase 14 | / | 0.519 | |
| 3hv7 | 1AU | Mitogen-activated protein kinase 14 | / | 0.516 | |
| 2e2b | 406 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.514 | |
| 3nnx | EDD | Mitogen-activated protein kinase 14 | / | 0.513 | |
| 3uvr | 06F | Mitogen-activated protein kinase 14 | / | 0.513 | |
| 3p79 | P79 | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 3vhe | 42Q | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.508 | |
| 1wbn | L09 | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 1w82 | L10 | Mitogen-activated protein kinase 14 | / | 0.499 | |
| 3kq7 | KQ7 | Mitogen-activated protein kinase 14 | / | 0.499 | |
| 1wbs | LI2 | Mitogen-activated protein kinase 14 | / | 0.495 | |
| 3k3j | F4C | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 4u0i | 0LI | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.493 | |
| 5hid | B1E | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.491 | |
| 2hzn | KIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.490 | |
| 3gcu | R48 | Mitogen-activated protein kinase 14 | / | 0.490 | |
| 2hz0 | GIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.488 | |
| 2hiw | 7MP | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.487 | |
| 3e93 | 19B | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 2puu | G2G | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 1wbv | LI3 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 4h1m | 0YJ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.481 | |
| 4aa0 | AA0 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 1kv2 | B96 | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 3orn | 3OR | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.475 | |
| 3p7c | P7C | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 3gvu | STI | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.474 | |
| 3p7a | P7A | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 4hw7 | 64M | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.472 | |
| 4eh9 | 0OQ | Mitogen-activated protein kinase 14 | / | 0.470 | |
| 4kig | ENO | Phenylpyruvate C(3)-methyltransferase | 2.1.1.281 | 0.467 | |
| 3nnw | EDD | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 4an9 | 2P7 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.463 | |
| 3gcv | SS6 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 4h4z | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.462 | |
| 3vvh | 4BM | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.460 | |
| 3p78 | P78 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 1j39 | UPG | DNA beta-glucosyltransferase | / | 0.457 | |
| 4h4x | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.457 | |
| 1s9j | BBM | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.455 | |
| 2vwp | NDP | Glucose 1-dehydrogenase | / | 0.451 | |
| 4ei7 | GDP | Plasmid replication protein RepX | / | 0.450 | |
| 1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 2yis | YIS | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 2p55 | MRA | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.446 | |
| 5dhh | DGW | Nociceptin receptor | / | 0.446 | |
| 2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.444 | |
| 4c2u | ANP | DNA helicase | / | 0.444 | |
| 4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.444 | |
| 3v04 | V04 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.443 | |
| 4l8m | F46 | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
| 3v01 | 3V0 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.442 | |
| 1rdw | LAR | Actin, alpha skeletal muscle | / | 0.441 | |
| 2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.441 | |
| 4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.441 | |
| 2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2yy8 | MTA | tRNA (cytidine(56)-2'-O)-methyltransferase | / | 0.440 | |
| 3aid | ARQ | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.440 |